Effects of oral sotalol administration before electrical cardioversion of persistent atrial fibrillation

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2001-08, Vol.22 (16), p.1512-1514
1. Verfasser: Veloso, H H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1514
container_issue 16
container_start_page 1512
container_title European heart journal
container_volume 22
creator Veloso, H H
description
doi_str_mv 10.1053/euhj.2001.2615
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71058572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71058572</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-257919c7dbc8102ec1bc3447318b61d8e3b92491d87ae06aa5df855d4907b1f63</originalsourceid><addsrcrecordid>eNpFkE1LAzEQhoMoWj-uHmVP3rZmkk2yOYrfUhSKQvESstkEo9umJlvRf2_WFj3NwDzvy_AgdAx4DJjRM7t6fRsTjGFMOLAtNAJGSCl5xbbRCINkJef1bA_tp_SGMa458F20B1DVRBI-Qq9XzlnTpyK4IkTdFSn0ugtdodu5X_jUR937sCga60K0he0yHL3JoNGx9eHTxjTcc3w5rKm3i77QmcmI8030XffbcIh2nO6SPdrMA_R8ffV0cVtOHm_uLs4npaFc9iVhQoI0om1MDZhYA42hVSUo1A2Htra0kaSSeRPaYq41a13NWFtJLBpwnB6g03XvMoaPlU29mvtkbP5iYcMqKZG11UyQDI7XoIkhpWidWkY_1_FbAVaDWzW4VYNbNbjNgZNN86qZ2_Yf38jMQLkGBgtff3cd3xUXVDB1O3tRdHJPYfowVZf0B_5HhtA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71058572</pqid></control><display><type>article</type><title>Effects of oral sotalol administration before electrical cardioversion of persistent atrial fibrillation</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Veloso, H H</creator><creatorcontrib>Veloso, H H</creatorcontrib><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1053/euhj.2001.2615</identifier><identifier>PMID: 11482926</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Administration, Oral ; Anti-Arrhythmia Agents - therapeutic use ; Atrial Fibrillation - drug therapy ; Electric Countershock ; Humans ; Magnesium - therapeutic use ; Sotalol - therapeutic use</subject><ispartof>European heart journal, 2001-08, Vol.22 (16), p.1512-1514</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-257919c7dbc8102ec1bc3447318b61d8e3b92491d87ae06aa5df855d4907b1f63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11482926$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Veloso, H H</creatorcontrib><title>Effects of oral sotalol administration before electrical cardioversion of persistent atrial fibrillation</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><subject>Administration, Oral</subject><subject>Anti-Arrhythmia Agents - therapeutic use</subject><subject>Atrial Fibrillation - drug therapy</subject><subject>Electric Countershock</subject><subject>Humans</subject><subject>Magnesium - therapeutic use</subject><subject>Sotalol - therapeutic use</subject><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1LAzEQhoMoWj-uHmVP3rZmkk2yOYrfUhSKQvESstkEo9umJlvRf2_WFj3NwDzvy_AgdAx4DJjRM7t6fRsTjGFMOLAtNAJGSCl5xbbRCINkJef1bA_tp_SGMa458F20B1DVRBI-Qq9XzlnTpyK4IkTdFSn0ugtdodu5X_jUR937sCga60K0he0yHL3JoNGx9eHTxjTcc3w5rKm3i77QmcmI8030XffbcIh2nO6SPdrMA_R8ffV0cVtOHm_uLs4npaFc9iVhQoI0om1MDZhYA42hVSUo1A2Htra0kaSSeRPaYq41a13NWFtJLBpwnB6g03XvMoaPlU29mvtkbP5iYcMqKZG11UyQDI7XoIkhpWidWkY_1_FbAVaDWzW4VYNbNbjNgZNN86qZ2_Yf38jMQLkGBgtff3cd3xUXVDB1O3tRdHJPYfowVZf0B_5HhtA</recordid><startdate>20010801</startdate><enddate>20010801</enddate><creator>Veloso, H H</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010801</creationdate><title>Effects of oral sotalol administration before electrical cardioversion of persistent atrial fibrillation</title><author>Veloso, H H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-257919c7dbc8102ec1bc3447318b61d8e3b92491d87ae06aa5df855d4907b1f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Administration, Oral</topic><topic>Anti-Arrhythmia Agents - therapeutic use</topic><topic>Atrial Fibrillation - drug therapy</topic><topic>Electric Countershock</topic><topic>Humans</topic><topic>Magnesium - therapeutic use</topic><topic>Sotalol - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Veloso, H H</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Veloso, H H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of oral sotalol administration before electrical cardioversion of persistent atrial fibrillation</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>2001-08-01</date><risdate>2001</risdate><volume>22</volume><issue>16</issue><spage>1512</spage><epage>1514</epage><pages>1512-1514</pages><issn>0195-668X</issn><eissn>1522-9645</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>11482926</pmid><doi>10.1053/euhj.2001.2615</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2001-08, Vol.22 (16), p.1512-1514
issn 0195-668X
1522-9645
language eng
recordid cdi_proquest_miscellaneous_71058572
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals
subjects Administration, Oral
Anti-Arrhythmia Agents - therapeutic use
Atrial Fibrillation - drug therapy
Electric Countershock
Humans
Magnesium - therapeutic use
Sotalol - therapeutic use
title Effects of oral sotalol administration before electrical cardioversion of persistent atrial fibrillation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T22%3A07%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20oral%20sotalol%20administration%20before%20electrical%20cardioversion%20of%20persistent%20atrial%20fibrillation&rft.jtitle=European%20heart%20journal&rft.au=Veloso,%20H%20H&rft.date=2001-08-01&rft.volume=22&rft.issue=16&rft.spage=1512&rft.epage=1514&rft.pages=1512-1514&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1053/euhj.2001.2615&rft_dat=%3Cproquest_cross%3E71058572%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71058572&rft_id=info:pmid/11482926&rfr_iscdi=true